Drug Type Small molecule drug |
Synonyms DES 9384, DES9384 |
Target |
Action inhibitors |
Mechanism TRPA1 inhibitors(Transient receptor potential cation channel subfamily A member 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arthritis Pain | Phase 1 | - | 31 Dec 2023 | |
| Chronic cough | Phase 1 | - | 31 Dec 2023 | |
| Diabetic Neuropathies | Phase 1 | - | 31 Dec 2023 | |
| Low Back Pain | Phase 1 | - | 31 Dec 2023 | |
| Rheumatoid Arthritis | Phase 1 | - | 31 Dec 2023 |





